Sydney startup Medow Health AI, which is using artificial intelligence (AI) to automate medical reports for specialist doctors has raised $3 million in new funding from the clinicians who backed its first raise earlier this year.
Medow Health was cofounded by Joel Freiberg, who has Crohn’s disease, and his brother Josh, inspired by the time their father, a respiratory physician, spent doing admin after work.
The medtech startup previously raised $2 million in January, from the likes of Chris O’Brien Lifehouse CEO Dr Michael Boyer and orthopaedic surgeon Dr Michael Solomon, and eye surgeon Dr Johnny Wu, who invested again 10 months later in this second round.
Meanwhile, revenue has grown by 300% in 2025 and the platform’s AI is already processing more than 100,000 specialist consults a month, alongside a successful pilot at a leading Australian hospital.
Medow Health also expanded to New Zealand and then South East Asia and Joel Freiberg says they’ve had strong pick up in both regions
“The capital raise will enable us to launch new AI products to specialist medical communities across the country, increase integrations into key healthcare systems and see us through to profitability within 12 months,” he said.
“We didn’t have to look far for investors for both the initial and second round capital raise with our early medical specialist customers already using the technology wanting to be involved.”
The platform uses artificial intelligence to streamline processes, improve patient care, and enhance overall efficiency in healthcare. Freiberg said their goal is to create “a system that genuinely resonates” with the specialists using it.
“Where others only focus on AI we use our engineering talent to integrate with key medical systems, recently launching a tailored hospital product for meditech powered Chris O’Brien Lifehouse,” he said.
“Leading in AI quality and interoperability has been a key priority since day one and led to our amazing partnership with Magentus almost 3 years ago.”
“Our talent is shown by not only our AI capabilities but also our ability to work within existing healthcare ecosystems and that is our advantage, as evidenced by Meditech and Genie integrations with more to come.”
Daily startup news and insights, delivered to your inbox.